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Abstract 
Failure to cure eye infections, and reduced potency in topical antimicrobials had been observed in South Western Nigeria, this study 
sought to evaluate in vitro, the efficacy of antimicrobial agents in the treatment of ocular infections. A total of 46 ocular bacterial isolates 
were recovered from the diagnostic laboratory of the University College Hospital, Ibadan, from conjunctival swabs of patients having 
underlying eye diseases (Cataracts, glaucoma and esotrapia), and from patients presenting with other symptoms of eye infections. The 
pathogens incriminated were Staphylococcus aureus (73.5%), Coagulase negative Staphylococci (13.3%), Klebsiella species (10.3%), and 
Pseudomonas aeruginosa (2.0%). Disc diffusion tests (Bauer-Kirby method) were carried out using ciprofloxacin, gentamicin, 
chloramphenicol, erythromycin, augmentin, cefuroxime and levofloxacin. Broth dilution techniques were thereafter performed using 
gentamicin, chloramphenicol and ciprofloxacin. The microlide- erythromycin was 63.0% efficacious, augmentin and cefuroxime showed 
71.1% and 76% efficacy. Minimum inhibitory concentrations (MIC) of commonly used topical antibiotics however showed different 
levels of resistance. Resistance to the aminoglycosides was marked, yielding 53.4% with MIC50= 8, MIC90 > 256, Resistance to 
chloramphenicol was even more marked 69.6% with MIC50= 16, MIC90= 64, the fluoroquinolones showed high efficacy- levofloxacin 
and ciprofloxacin showed 93.4% and 82.6% susceptibility respectively with MIC50 < 0.5, though slightly demonstrable resistance was 
observed (MIC90= 8). The study thus recommends the discontinuation of empirical therapy by physicians in order to stem the tide of 
resistance; it justifies the inclusion of the fluoroquinolones in susceptibility testing of ocular bacterial isolates, and its first line of choice if 
cure is warranted. 
 
Introduction 
Ocular bacterial flora includes Corynebacterium xeroisis, 
Moraxella catarrhalis, and Staphylococcus epidermidis (1). 
The coagulase negative staphylococci, a subject of debate 
in the 1980s, regarding its role in pathogenicity, are 
remarkable for its opportunism. It has thus been 
incriminated in chronic blepharitis (2), corneal ulcers, and 
endophthalmitis after traumatic eye surgery (3). Globally, 
S. aureus is the leading cause of conjunctivitis (3). The 
incidence of methicillin resistant Staphylococcus aureus 
(MRSA) in ocular infections is on the rising side (4). In 
Onitsha, Nigeria, S. aureus is the leading cause of 
conjunctivitis and keratitis (5). Pseudomonas aeruginosa is 
also leading causes of corneal ulcers especially among 
contact lens wearers (6). Neisseria gonorrheae and 
Chlamydia trachomatis cause severe conjunctivitis in the 
newborn - ophthalmia neonatorum (7). Haemophilus 
species, Streptococcus pneumoniae (8) and non fermenting 
coliforms have been implicated in ocular infections (6).  
 
The aminoglycosides gentamicin and tobramycin are well 
established as first-line therapy for external ocular 
infections, and possess a broad spectrum of activity against 
Gram positive and Gram negative organisms (9,10). 
However, resistance to these antibiotics has been reported. 
For example, resistance to topical aminoglycoside therapy  
 
may be encountered in as many as 8% to 10% of ulcerative 
keratitis cases caused by Pseudomonas aeruginosa (11). 
Resistance appears to be even greater in ocular infections 
caused by Gram positive organisms (12). The in-vitro 
studies of antibacterial susceptibility tests by various 
authors have shown increasing resistance of commonly 
used antibacterials; gentamicin (21%) (4,13), 
chloramphenicol, though potent against MRSA strains, has 
just been demonstrated to show significant reduction in its 
bacteriostatic action in Europe (14.1%), (14). However, 
ciprofloxacin, which is still comparatively the most 
efficacious, has also shown reduced potency; resistance at 
35% was shown in Pittsburg, USA (15), ciprofloxacin has 
also shown reduced potency against ocular MRSA isolates 
in the United States (16).  
These differing levels of resistance impel an evaluation of 
these drugs in Nigeria in order to ascertain their efficacy 
and have a documented level of susceptibility to these 
agents. The study was therefore aimed at evaluating in-
vitro susceptibility patterns of ocular clinical isolates to 
commonly used antibiotics, with emphasis on gentamicin, 
chloramphenicol and ciprofloxacin due to the availability 






Materials and Methods 
Bacterial strains 
A total of 46 bacterial isolates were isolated by standard 
procedures (17) from 136 eye swabs and scrapings sent to 
the diagnostic laboratory of Medical Microbiology and 
Parasitology department, University College Hospital, 
Ibadan from January to October 2009.  
 
 
Disc susceptibility testing  
Varying concentrations of antibiotics discs; gentamicin (10 
µg), ciprofloxacin (10 µg), methicillin (5 µg), 
chloramphenicol (10 µg), erythromycin (5 µg), ampicillin 
(10 µg), cloxacillin (5µg), cefuroxime (30 µg), augmentin 
(10 µg), and levofloxacin (10 µg) were used. Inhibition 
zone diameters around the discs were measured to the 
nearest millimetre using a calibrated transparent ruler. The 
susceptible inhibition zone diameter break point used 
throughout the study for each antibiotic to the various 
organisms was based on CLSI recommendation (18). The 
diameters of the zone of inhibition were recorded. Growth 
within the zone of inhibition was recorded as resistant (18). 
Sensitivity patterns for Staphylococcus, Pseudomonas 
Klebsiella were compared with the standard 
ATCC 29213; P. aeruginosa NCTC 10662 and 
NCTC 10418, respectively.  
 
Minimum inhibitory concentration  
The minimum inhibitory concentration (MIC) of 3 
antibiotics; gentamicin, chloramphenicol and ciprofloxacin 
for all the bacterial strains was determined as described by 
Goldstein and Acar (19). The antibiotics were supplied in 
powdery formulations, namely; gentamicin, 
chloramphenicol and ciprofloxacin by SIGMA
U.K. Serial doubling dilutions of these antibiotics were 
made, ranging from 0.0625 to 512 µg/ml.  A drop (0.02 ml) 
of standard inoculum (0.5 Macfarland) of organisms was 
introduced and these were then incubated at 37
hours. MIC was interpreted as the least concentration or 
highest dilution with no observable turbidity. Controls were 
set up namely; sterility control: Mueller Hinton broth only, 
viability control: Mueller Hinton broth and test organism, 
positive control: Mueller Hinton broth with antibiotics and 




Bacteria isolates recovered were Staphylococcus aureus
(73.9%), coagulase negative staphylococci 
Klebsiella species 5 (10.8%) and Pseudomonas aeruginosa
1 (2.2%). The distribution of the various isolates with 
underlying eye conditions, and ocular infections are shown 
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Figure 1: Percentage (%) distribution of conjunctival 




All the strains examined showed resistance to one or more 
of the eight antibiotics used for this study. The results 
depicted a high level resistance. The fluoroquinolones 
showed slightly lower level of resistance than the rest of the 
antibiotics including the third generation cephalosporins. 
More isolates were sensitive to levofloxacin (93.4%) and 
ciprofloxacin (76%) than all the antibiotics tested (Table 1). 
Similarly, susceptibility of the strains to methicillin was 
10.4%; 30.4% for chloramphenicol while 
41.3% (Figure 2). It is noteworthy that chloramphenicol 
had no activity against Klebsiella species and 
aeruginosa in this study. 
 
Figure 2: Percentage susceptibility to chloramphenicol, 
















The MIC results also showed that the level of resistance to 
many antibiotics was high. MIC50 and MIC90 of 
ciprofloxacin were lower than the rest of the antibiotics. 
MIC90 of gentamicin to the strains was very high with value 
>256 µg/ml (Table 2).  
 
Discussion 
The study showed S.  aureus as the most frequently 
incriminated conjunctival pathogen, this is consistent with 
previous studies in Nigeria (20), and outside the country 
(21). Methicillin-resistant S. aureus (MRSA) and 
Methicillin resistant coagulase negative staphylococci 
(MRCNS) are intraocular pathogens. They all however 
have a common source; the anterior nares (22), which via 
the nasolacrimal duct, may reach the conjunctiva or infect 
deeper ocular structures; endophthalmitis may ensue (23). 
The isolation of MRSA from patients having cataracts and 
glaucoma (92.3%) is therefore alarming. The definitions of 
these conditions do not presuppose a microbial cause. Their 
incrimination may thus imply the likelihood of subsequent 
infections that further destroy ocular tissues, and increased 
susceptibility of these patients to ocular infections. 
Ultimately, if it be ascertained that these pathogens are 
simply microflora, it should be alarming from a general 
epidemiological perspective of resistance, as well as the 
serious dangers posed these patients if a surgery would be 
carried out to correct these conditions. 
                                      
Table 1: Susceptibility patterns of bacterial pathogens using disc diffusion 
 
Organism     MET       CHL     GEN     CIP     ERY     AUG     LEV     CXM 
 S     I      R  S     I      R S     I      R S     I      R S     I      R S     I      R S     I      R S     I      R 
S. aureus (34) 3      0      31 11     0      23 14    2     18  26    2     6 24    0     10 27    0     7 31    0     3 30    0     4 
CNS (5) 2      0      3 1      0      4 2      0      3 4      0     1      3      0     2      3      0     2      5      0     0      3      0     2      
Klebsiella spp (5) 0      0      5 0      0      5 2      0      3 4      0     1      2      0     3      2      0     3      5      0     0      2      0     3      
P. aeruginosa (1) 0      0      1 0      0      1 1      0      0 1      0     0      0      0     1      1      0     0      1      0     0      0      0     1      
 
MET- methicillin, CHL- chloramphenicol, GEN- gentamicin, CIP- ciprofloxacin, ERY-erythromycin, AUG- augmentin,  
LEV- levofloxacin, CXM- cefuroxime, S- susceptible, I- intermediate, R- resistant. 
 
Table 2: Minimum inhibitory concentrations of common antimicrobials to the pathogens 
Organism Antimicrobial 
Agent 
MIC50 (µg/ml) MIC90 (µg/ml) Range (µg/ml) 









0.25 – 256 
0.25 – 256 
0.25 – 256 









0.25 – 256 
0.25 – 256 
0.25 – 256 









0.25 – 256 
0.25 – 256 
0.25 – 256 









0.25 – 256 
0.25 – 256 
0.25 – 256 
 
The coagulase negative staphylococci generate fewer 
controversies on its pathogenicity these days. They have 
been incriminated in chronic blepharits (2), Keratitis (24), 
and endophthalmitis (22). In Nigeria, the pathogenicity of 
the CNS has been established and is incriminated in various 
disease conditions; Ogbolu et al. thus advocate processing 
when isolated from repeated cultures (25). Their 
incrimination and inclusion in this study is thus not 
surprising, and their resistance patterns justify the 
discourse, which further show that resistance mechanisms 
are equally been evoked by these organisms, thus 
increasing their endemic status and enhancing their 
pathogenicity, especially when they reach deeper 
structures.  
Most ocular isolates showed resistance using disc diffusion 
techniques to gentamicin (54.6%) but more marked levels 
of resistance was demonstrated (MIC50 = 32, MIC90 >256 
µg/ml) by broth dilution technique. Resistance to Gram  
 
 
negative rods and Staphylococcus aureus including MRSA 
strains was demonstrated. Third generation fluoroquinolone 
- levofloxacin was most efficacious using the disc diffusion 
test technique (93.4%). The efficacy of this drug buttresses 
the reliability of the fluoroquinolones against conjunctival 
bacterial pathogens, especially the MRSA. Ciprofloxacin 
also had demonstrable clinical efficacy using both 
techniques. Susceptibility of MRSA strains was 83% using 
disc diffusion test, confirmed by broth dilution techniques 
(MIC50 < 0.5). Resistance was however also demonstrated, 
with MIC90 = 8.0 µg/ml. These results are in sharp variance 
with Kotlus et al’s observation in the United States, where 
94% resistance to ciprofloxacin was observed, with MIC50 
= 8.0 µg/ml, in the study, gentamicin was most efficacious  
(16). The efficacy of ciprofloxacin has also been 
demonstrated in Nigeria, this conforms to the study of Idu 
et al. where it was found to be most potent among other 




Abuse of fluoroquinolones in the U.S may have led to the high rate of resistance to this 1
potent drug, whereas it’s comparatively new status in 
Nigeria still ensures its potency.  
On definitive prophylaxis pre-ocular surgery, this study 
may be quick to recommend the use of ciprofloxacin in 
topical formulations in Nigeria. However, discouragement 
of empirical therapy for the treatment of ocular infections is 
essential considering the increasing levels of resistance to 
commonly used antibiotics as has been shown in this study. 
The study affirms the high levels of the superbug MRSA 
among these species in eye infections in Nigeria, having 
varying resistance patterns. It also quantitatively validates 
reports of significantly reduced potency to commonly used 
topical antimicrobials - gentamicin and chloramphenicol. It 
however shows the fluoroquinolones as unparalleled in the 
treatment of ocular infections. We therefore advocate for 
discontinuation of empirical therapy by physicians, and 
advise isolation of the causative bacterial agents, and 
subsequent susceptibility testing which should include the 
fluoroquinolones. The inability to isolate typically 
fastidious ocular pathogens like Streptococcus pneumoniae, 
Haemophilus influenzae, and Haemophilus aegypticus, 
should impel a clamour for the use of transport swabs in 
routine diagnosis of eye infections. Periodic re-evaluation 
of antimicrobial agents is essential in order to guide 
therapy, as well as to track and monitor resistance by 
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